The literature shows that lncRNA CERS6-AS1 is used in the research and analysis of a variety of cancer processes, such as hepatocellular carcinoma [35], pancreatic cancer [25,36], breast cancer [28], and most of them are related to the poor prognosis of tumors by targeting miRNAs. Here, CERS6 is linked to breast cancer.